LRMR News and Press, Larimar Therapeutics Inc. From 02/24/26

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 5.2% to $1.6499 on volume of 551,178,425 shares Blue Hat Interactive Entertainment Technology (BHAT) rose 9.3% to $0.0719 on volume of 251,273,331 shares Reliance Global Group Inc....

2026-01-16 06:17:31 ET I don't usually spend my time digging through clinical-stage biotechs. My typical picks are undervalued shippers or mispriced subprime lenders where you can touch the assets or model the cash flows with some degree of certainty. But occasionally, a setup comes alo...

2026-01-14 14:36:00 ET Larimar Therapeutics, Inc. (LRMR) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 12:00 PM EST... Read the full article on Seeking Alpha For further details see: Larimar Therapeutics, Inc. (LRMR) Presents at 44th Annual J.P. Morgan Healt...

BALA CYNWYD, Pa., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that members of the company’s management team will present and partici...

2025-11-06 16:59:15 ET Shares of gene therapy concern Lexeo Therapeutics, Inc. ( LXEO ) have roughly tripled since a financing in May 2025, partly on the back of FDA alignment on a registrational trial for its LX2006 therapy. Announced on October 7th, its pivotal study...

2025-11-05 12:28:51 ET More on Larimar Therapeutics Larimar Therapeutics, Inc. (LRMR) Discusses On The Nomlabofusp Program For The Treatment Of Friedreich's Ataxia Conference Call (Transcript) Seeking Alpha’s Quant Rating on Larimar Therapeutics Historical ear...

In the open label (OL) study, after 6-months of daily nomlabofusp administration, 100% of participants (n = 10) achieved skin FXN levels similar to asymptomatic carriers Consistent directional improvement across mFARS, FARS-ADL, 9-HPT and MFIS after 1-year in OL study reinforces the poten...

Curaleaf Holdings Inc (CURLF) is expected to report $-0.07 for Q3 2025 Southwest Gas Holdings Inc. (DE) (SWX) is expected to report $0.09 for Q3 2025 Terreno Realty Corporation (TRNO) is expected to report $0.65 for Q3 2025 Bio-Techne Corp (TECH) is expected to report $0.36 for Q1 202...

Amerigo Resources Ltd (ARREF) is expected to report $0.06 for Q3 2025 Bausch + Lomb Corporation (BLCO) is expected to report $0.16 for Q3 2025 Hayward Holdings Inc. (HAYW) is expected to report $0.11 for Q3 2025 Automatic Data Processing Inc. (ADP) is expected to report $2.44 for Q1 2...

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Larimar Therapeutics, Inc. (“Larimar” or “the Company”) (NASDAQ: LRMR ) for violations of the securities laws. The investi...